21:14 · 4 āļāļļāļĄāļ āļēāļžāļąāļ™āļ˜āđŒ 2025

Palantir shares surge 23% driven by earnings and sales upbeat 📈

The US technology & defence company, Palantir (PLTR.US) stock surged over 23% in after-hours trading following a 36% year-over-year revenue increase in Q4, reaching $827.5 million. The company forecasts 2025 revenue of $3.75 billion, exceeding analysts’ expectations. U.S. government revenue rose by 45% YoY to $343 million, while commercial revenue soared by 64% to $214 million.

Palantir Technologies provided an optimistic outlook, highlighting strong demand driven by artificial intelligence. CEO Alex Karp pointed to rapid organic growth in AI adoption across government and commercial sectors, fuelling investor confidence in the company's business expansion.

  • Q4 Revenue: $827.5 million (+36% YoY), exceeding the $775.9 million consensus.
  • Q4 Adjusted EPS: $0.14 (vs. $0.08 YoY), beating the $0.11 estimate.
  • Q4 Adjusted Operating Profit: $372.5 million (+78% YoY), surpassing the $309.6 million forecast.
  • 2025 Revenue Guidance: $3.74–3.76 billion (vs. consensus of $3.54 billion).
  • 2025 Adjusted Operating Profit: $1.55–1.57 billion (vs. consensus of $1.37 billion).
  • 2025 Free Cash Flow (Adjusted): Projected at $1.5–1.7 billion.

Palantir’s AI-driven expansion and growing U.S. government contracts have fueled positive sentiment among analysts. Morgan Stanley remains bullish, citing improving fundamentals and raising its price target to $95 (previously $60). Analysts highlight record revenue growth and sustained momentum.

Source: XTB Research, Bloomberg Finance L.P.

Operational Strength

  • Government Sector Growth: U.S. government revenue surged 45% to $343 million, supported by expanding military and intelligence applications.
  • Commercial Expansion: U.S. commercial revenue climbed 64% to $214 million, expected to reach $1.08 billion (+54%) in 2025.
  • Defense Ecosystem Expansion: Palantir deepened its partnerships with defense tech firms like Anduril and AI startup Anthropic, reinforcing its role in the modern U.S. defense infrastructure.

Palantir’s strong revenue growth and AI-driven demand signal a promising trajectory, particularly in U.S. markets. While the company outperformed expectations, concerns remain regarding international sales slowdown and valuation. However, pre-market gains suggest investor optimism remains strong.

Source: xStation5

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩāļŸāļĢāļĩ

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩāļ‚āļ­āļ‡āļ„āļļāļ“āđ„āļ”āđ‰āļ­āļĒāđˆāļēāļ‡āļĢāļ§āļ”āđ€āļĢāđ‡āļ§āđ‚āļ”āļĒāđ„āļĄāđˆāļ•āđ‰āļ­āļ‡āļœāđˆāļēāļ™āļ‚āļąāđ‰āļ™āļ•āļ­āļ™āļĒāļļāđˆāļ‡āļĒāļēāļ āļāļēāļĢāļāļēāļāđāļĨāļ°āļ–āļ­āļ™āđ€āļ‡āļīāļ™āđ‚āļ”āļĒāđ„āļĄāđˆāļĄāļĩāļ„āđˆāļēāļ˜āļĢāļĢāļĄāđ€āļ™āļĩāļĒāļĄ

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩ  āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļ­āļ› 
19 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 09:31

āļ‚āđˆāļēāļ§āđ€āļ”āđˆāļ™āļ§āļąāļ™āļ™āļĩāđ‰ 19 āļŠ.āļ„.

19 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 09:27

Apple āļŠāļ§āļ™āļ—āļēāļ‡ Nasdaq āļĢāđˆāļ§āļ‡āļŦāļ™āļąāļ! ðŸ›Ąïļ āļŦāļĢāļ·āļ­āļˆāļ°āđ€āļ›āđ‡āļ™āļŦāļļāđ‰āļ™āļŦāļĨāļšāļ āļąāļĒāļˆāļēāļāļāļĢāļ°āđāļŠ AI?

18 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 08:34

SpaceX āļĒāļąāļ‡āđ„āļĄāđˆāļĒāļ­āļĄāļ–āļ­āļĒ ðŸ’Ĩ āļ­āļ°āđ„āļĢāļ­āļēāļˆāļŦāļĒāļļāļ”āđāļĢāļ‡āļ‹āļ·āđ‰āļ­āļ‚āļ­āļ‡āļšāļĢāļīāļĐāļąāļ— â€œStellar” āļ‚āļ­āļ‡ Musk āđ„āļ”āđ‰? 🚀

17 āļŠāļīāļ‡āļŦāļēāļ„āļĄ 2026, 20:20

Market Wrap: āļŦāļļāđ‰āļ™āļŠāļīāļ›āļĒāļļāđ‚āļĢāļ›āļžāļļāđˆāļ‡āđāļĢāļ‡ āļŦāļĨāļąāļ‡āļœāļĨāļ›āļĢāļ°āļāļ­āļšāļāļēāļĢāļ‚āļ­āļ‡ Anthropic! AstraZeneca āļĢāļ°āļ‡āļąāļšāļāļēāļĢāļ—āļ”āļĨāļ­āļ‡āļĒāļēāļĢāļąāļāļĐāļēāļĄāļ°āđ€āļĢāđ‡āļ‡āļ›āļ­āļ”

āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ—āļĩāđˆāđ€āļĢāļēāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡ āđ€āļĻāļĐāļŦāļļāđ‰āļ™ (Fractional Shares) āđ€āļ›āđ‡āļ™āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļĩāđˆāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļˆāļēāļ XTB āđāļŠāļ”āļ‡āļ–āļķāļ‡āļāļēāļĢāđ€āļ›āđ‡āļ™āđ€āļˆāđ‰āļēāļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļšāļēāļ‡āļŠāđˆāļ§āļ™āļŦāļĢāļ·āļ­ ETF āđ€āļĻāļĐāļŦāļļāđ‰āļ™āđ„āļĄāđˆāđƒāļŠāđˆāļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ­āļīāļŠāļĢāļ° āļŠāļīāļ—āļ˜āļīāļ‚āļ­āļ‡āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ­āļēāļˆāļ–āļđāļāļˆāļģāļāļąāļ”
āļ„āļ§āļēāļĄāļŠāļđāļāđ€āļŠāļĩāļĒāļŠāļēāļĄāļēāļĢāļ–āđ€āļāļīāļ™āļāļ§āđˆāļēāđ€āļ‡āļīāļ™āļ—āļĩāđˆāļāļēāļ